Clinical trial

Biweekly Gemcitabine and Docetaxel as First Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients

NCT00906061

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2007-10-01

PhasePHASE2

Study timeline

Study start (unknown)2007-10-01Date precision: month

Registry last updated2009-05-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Carcinoma, Non-Small-Cell Lungunresolved

Interventions

Gemcitabine and DocetaxelDRUG

Sponsors & collaborators

Hospital Arnau de Vilanovalead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00906061 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.